# Biomat USA Inc – FDA Inspection, Apr 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f02962e7-eb88-4794-b66a-357a628d8fe2
Source feed: FDA_Inspections

> FDA inspection 1049621 of Biomat USA Inc, April 24, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 640. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1049621
- Company Name: Biomat USA Inc
- Inspection Date: 2018-04-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1179250 - 2022-08-29
- FDA Inspection 953240 - 2015-12-21
- FDA Inspection 838107 - 2013-07-02
- FDA Inspection 717043 - 2011-04-13

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/biomat-usa-inc/fa22ecc1-b4a0-4c05-b4ed-cc9c7d6a616b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d